drugset / Trial / NCT07813182

Efficacy and Safety of Saccharomyces Boulardii in Treatment of Acute Diarrhea in Children Aged 6 Months to 5 Years Old

NCT07813182 ↗

Not yet recruiting 206 enrolled Can Tho University of Medicine and Pharmacy
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to evaluate the effectiveness of saccharomyces-based treatment in children with acute diarrhea aged 6 months to 5 years compared to children treated with standard methods.

Timeline

Start
2026-08-31
Primary completion
2028-08-30
Completion
2028-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Saccharomyces boulardii Other / unclassified 250 mg —
Subject Saccharomyces boulardii Other / unclassified 750 mg —

Indications